Circular RNA Biology: Detection, Function and Experimental Pitfalls

Circular RNAs are real, abundant, and frequently over-interpreted.

Introduction: A Real Molecule With a Fragile Literature

Circular RNAs are produced by back-splicing, in which a downstream splice donor joins an upstream acceptor, creating a covalently closed loop. They are abundant in some tissues, stable because they lack free ends, and in a few well-documented cases functionally important.

They are also the subject of a large literature in which the molecule's existence, its abundance, and its function are established with unequal rigor. Three problems recur: detection artifacts (signals that look circular but are not), abundance confusion (copy numbers too low to support a stoichiometric function), and overexpression artifacts (phenotypes produced by non-physiological levels).

Part 1 — Biogenesis, Briefly

RouteMechanismNotes
Exon skipping / lariat-drivenBack-splicing joins flanking exonsMost common in mammals
Intron pairing (reverse complementarity)Flanking intronic repeats bring splice sites togetherExplains many tissue-specific circRNAs
RBP-mediatedRNA-binding proteins bridge splice sitesCandidate-specific
tRNA/intron lariatsNon-canonical circularizationDistinct biology from exon-derived circRNAs

Flanking intronic repeats and RBP binding are the two features most predictive of whether a given exon circularizes — useful when deciding which candidate to pursue.

Part 2 — Detection: Where False Positives Come From

MethodWhat it detectsPrincipal artifact
Divergent primers (RT-PCR)A back-splice junctionGenomic rearrangements and tandem duplications produce the same product
RNase R resistanceClosed, exonuclease-resistant RNAIncomplete digestion; structured linear RNAs can appear resistant
Short-read RNA-seq + circRNA callersBack-splice junction readsFalse calls from misalignment; low abundance under-detected
Long-read sequencingFull-length circular sequenceDepth and library bias
Microarray / Nanostring panelsPredicted junctionsCross-hybridization to linear isoforms

The validation combination that holds up: divergent primers confirmed by Sanger sequencing of the junction, RNase R resistance with a linear control, and — where available — long-read confirmation. Two of the three, not one.

The most common artifact is a genomic duplication or rearrangement that produces a junction indistinguishable from a back-splice event by PCR alone. Sequencing the junction and checking the genomic locus resolves it.

Part 3 — Abundance: The Constraint Nobody Reports

CircRNA function claims often require stoichiometry: a sponge must be present at comparable copy number to its target miRNA; a scaffold must be present at sufficient concentration to assemble complexes.

Practical measurements rarely reported:

  • • Absolute copies per cell, from spike-in normalized quantification.
  • • Ratio to the linear isoform from the same locus.
  • • Ratio to the proposed interaction partner.

A circRNA present at a few copies per cell cannot sponge a miRNA present at hundreds. Papers that omit these numbers cannot support stoichiometric claims, which is the majority of the sponge literature.

Part 4 — Which Function Claims Survive

ClaimStrength of evidence required
"This circRNA is expressed in tissue X"Junction sequencing, RNase R, abundance
"It binds protein Y"RIP or CLIP with linear controls; stoichiometry
"It sponges miRNA Z"Absolute copy numbers for both, plus de-repression of targets
"It is translated"Ribosome profiling or mass spectrometry evidence of the junction peptide
"It is required for phenotype"Loss-of-function with rescue; not overexpression alone

The fifth row is the load-bearing one. Overexpression of a circRNA to high levels will produce phenotypes through sequestration of almost any abundant RNA-binding protein; that is a property of the experiment, not necessarily of the molecule.

Part 5 — Experimental Pitfalls

  • • Overexpression artifacts. Plasmid-driven circRNA expression can exceed physiological levels by orders of magnitude; phenotypes do not transfer.
  • • Back-splice junction effects. Overexpressed minigene constructs can generate linear species from the same vector; verify what is actually produced.
  • • siRNA against a junction. Knockdown of a circRNA with siRNA risks silencing the linear isoform if the siRNA also matches it; design junction-specific reagents and verify specificity.
  • • Knockout of the locus. Deleting the genomic region removes the linear isoform too; interpret as a locus-level perturbation unless the circularization signal is specifically disrupted.
  • • Translation claims. Detection of a junction-spanning peptide requires mass spectrometry with a synthetic standard, not just a predicted ORF.

Part 6 — A Minimal Standard for a circRNA Paper

  1. Junction sequence confirmed (Sanger or long-read).
  2. RNase R resistance with a linear control; genomic locus checked for rearrangement.
  3. Absolute abundance and ratio to linear isoform.
  4. Loss-of-function, not only gain-of-function.
  5. For interaction claims, stoichiometry of both partners.
  6. For translation claims, peptide-level evidence.

Papers that meet all six exist and are convincing. Papers that meet only the first two are describing expression, which is a legitimate but much smaller claim.

Need circRNA claims tested at physiological levels?

EDITGENE builds models for circRNA work: locus-level and circularization-specific perturbations, isogenic lines with verified junction sequences, and quantification with spike-in standards for absolute abundance.

Tell us the circRNA and the claim. Contact EDITGENE to request a project consultation or quote.

Scientific scope and validation note

Detection performance varies by method, abundance, and sequence; junction-level confirmation is required before a circular species is reported.

Function claims require loss-of-function evidence and, for stoichiometric mechanisms, absolute abundance measurements for both partners.

Selected references for further reading

  • • Kristensen LS, et al. The biogenesis, biology and characterization of circular RNAs. Nature Reviews Genetics. 2019;20:675–691.
  • • Jeck WR, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19:141–157.
  • • Szabo L, Salzman J. Detecting circular RNAs: bioinformatic and experimental challenges. Nature Reviews Genetics. 2016;17:679–692.
  • • Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nature Reviews Molecular Cell Biology. 2020;21:475–490.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: